Hemofarm Executive and Leadership Team

Dr. Seeliger, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm, directs overarching strategy and operational execution across the Balkan region for Hemofarm and the Stada cluster. This leadership role involves setting the strategic vision to maintain Hemofarm's position as the leading pharmaceutical company in Serbia, a market where it holds a substantial 17.3% financial share. Dr. Seeliger oversees the company's significant export activities, which account for 79.1% of Serbian pharmaceutical product exports, underscoring Hemofarm's critical role as a national exporter. The executive's purview includes managing the production of over 4 billion tablets and capsules annually, ensuring efficient operations and high-quality output. Dr. Seeliger's strategic direction is vital for expanding market reach and solidifying Hemofarm's commitment to care for health across its operational territories. This executive leadership ensures alignment with Stada's global objectives while championing Hemofarm's regional dominance and commitment to pharmaceutical excellence.

Vidosava Aleksic, the Chief Financial Officer, Pomocnik, directs Hemofarm's financial strategy, ensuring fiscal health and sustainable growth. This executive leadership is paramount in managing the financial aspects of Hemofarm's operations, including its significant market share of 17.3% in Serbia and its dominant 79.1% share in the export of Serbian pharmaceutical products. Vidosava Aleksic oversees budgeting, financial planning, and investment strategies that support the company's extensive production capacity, which exceeds 4 billion tablets and capsules annually. The CFO's role involves optimizing financial performance to reinforce Hemofarm's commitment to care for health and its status as a leading regional pharmaceutical company. Vidosava Aleksic ensures compliance with all financial regulations and drives initiatives to enhance profitability and shareholder value, thereby supporting the company's ambitious export goals and overall market leadership. This financial oversight is crucial for maintaining operational efficiency and strategic expansion.

Tijana Marković, the Chief Marketing Officer, Fmd & Specialist, spearheads all marketing initiatives and brand strategy for Hemofarm's diverse product portfolio. This role is critical in maintaining and growing Hemofarm's leading market share in Serbia, which stands at 17.3% financially. Tijana Marković drives the development and execution of innovative marketing campaigns that resonate with consumer health needs, reinforcing the company's core commitment to care for health. The executive's responsibilities extend to enhancing Hemofarm's brand visibility and market penetration, both domestically and in export markets where the company holds a dominant 79.1% share of Serbian pharmaceutical product exports. Overseeing specialist marketing functions, Tijana Marković ensures that product positioning aligns with scientific advancements and market demands, contributing directly to the company's robust production output of over 4 billion tablets and capsules annually. This leadership ensures that Hemofarm's pharmaceutical offerings reach their intended audiences effectively, supporting the company's mission and regional influence.

Danijela Viciknez, the Regional Chief Marketing Officer, Head Supply Network, orchestrates Hemofarm's supply chain operations and regional marketing efforts, ensuring seamless product availability and market penetration. This dual responsibility is critical for maintaining Hemofarm's leadership in the Serbian pharmaceutical market, with its 17.3% financial share, and its substantial 79.1% export share of Serbian pharmaceutical products. Danijela Viciknez oversees the complex logistics required to support the production of over 4 billion tablets and capsules annually, ensuring efficient distribution across domestic and international markets. The executive's strategic management of the supply network directly impacts Hemofarm's ability to meet market demands and uphold its commitment to care for health. Furthermore, Danijela Viciknez's regional marketing oversight ensures that Hemofarm's brand presence is strong and competitive, reinforcing its status as the leading pharmaceutical exporter. This leadership integrates operational efficiency with market responsiveness, vital for sustained regional success.